SIERRA ONCOLOGY INC's ticker is SRRA and the CUSIP is 82640U404. A total of 33 filers reported holding SIERRA ONCOLOGY INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $108,043,000 | +71.6% | 1,964,770 | 0.0% | 1.96% | +91.8% |
| Q1 2022 | $62,971,000 | +96.1% | 1,964,770 | +33.0% | 1.02% | +147.2% |
| Q4 2021 | $32,117,000 | -0.8% | 1,477,320 | 0.0% | 0.41% | +16.0% |
| Q3 2021 | $32,383,000 | +12.6% | 1,477,320 | 0.0% | 0.36% | +22.3% |
| Q2 2021 | $28,763,000 | +13.0% | 1,477,320 | 0.0% | 0.29% | +22.3% |
| Q1 2021 | $25,454,000 | +7.5% | 1,477,320 | 0.0% | 0.24% | +15.0% |
| Q4 2020 | $23,681,000 | +50.2% | 1,477,320 | 0.0% | 0.21% | +4.5% |
| Q3 2020 | $15,763,000 | -11.8% | 1,477,320 | 0.0% | 0.20% | -21.4% |
| Q2 2020 | $17,876,000 | +23.2% | 1,477,320 | 0.0% | 0.25% | +3.3% |
| Q1 2020 | $14,507,000 | – | 1,477,320 | – | 0.24% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CAXTON CORP | 643,959 | $10,323,000 | 6.44% |
| Vivo Capital, LLC | 1,917,074 | $30,731,000 | 1.37% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 135,000 | $2,164,000 | 1.26% |
| Ghost Tree Capital, LLC | 200,000 | $3,206,000 | 0.71% |
| Telemetry Investments, L.L.C. | 22,349 | $358,000 | 0.60% |
| FRAZIER MANAGEMENT LLC | 202,803 | $3,251,000 | 0.25% |
| MANGROVE PARTNERS IM, LLC | 108,914 | $1,746,000 | 0.24% |
| Ikarian Capital, LLC | 318,890 | $5,111,000 | 0.22% |
| Sio Capital Management, LLC | 66,455 | $1,065,000 | 0.22% |
| Orbimed Advisors | 1,477,320 | $23,681,000 | 0.21% |